0001209191-23-050200.txt : 20230920
0001209191-23-050200.hdr.sgml : 20230920
20230920182236
ACCESSION NUMBER: 0001209191-23-050200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230920
FILED AS OF DATE: 20230920
DATE AS OF CHANGE: 20230920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jakeman David
CENTRAL INDEX KEY: 0001780556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 231267448
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.,
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-20
0
0001117480
CHIMERIX INC
CMRX
0001780556
Jakeman David
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
0
1
0
0
VP of Finance and Accounting
0
Stock Option (Right to Buy)
1.055
2023-09-20
4
A
0
18000
0.00
A
2033-09-19
Common Stock
18000
18000
D
1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.
/s/ Michael Alrutz, Attorney-in-Fact
2023-09-20